42
Participants
Start Date
February 9, 2011
Primary Completion Date
September 23, 2011
Study Completion Date
November 11, 2011
NPSP558
All patients will inject NPSP558 25 or 50 µg SC QD into alternating thighs in the morning via a multidose injection pen device.
Columbia University Medical Center, New York
University Physicians Group, Staten Island
Physician East PA, Greenville
University of Cincinnati Bone Health and Osteoporosis Center, Cincinnati
Indiana University School of Medicine, Indianapolis
Michigan Bone & Mineral Clinic PC, Detroit
Mayo Clinic Rochester, Rochester
University of Chicago Medical Center, Chicago
Cetero Research DGD Research Inc., San Antonio
Advance Medical Research LLC, Lakewood
The Vancouver Clinic, Vancouver
Massachusetts General Hospital, Boston
Lead Sponsor
Shire
INDUSTRY